Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

Shankar Siva on stereotactic body radiotherapy for primary renal cell carcinoma

Shankar Siva on stereotactic body radiotherapy for primary renal cell carcinoma

FromThe Lancet Oncology in conversation with


Shankar Siva on stereotactic body radiotherapy for primary renal cell carcinoma

FromThe Lancet Oncology in conversation with

ratings:
Length:
14 minutes
Released:
Jan 2, 2024
Format:
Podcast episode

Description

Senior Editor Owen Stretton talks to Professor Shankar Shiva from the Peter MacCallum Cancer Centre in Melbourne about the International Society of Stereotactic Radiosurgery’s new systematic review and practice guidelines for stereotactic body radiotherapy in primary renal cell carcinoma.Continue this conversation on social!Follow us today at...https://twitter.com/thelancet & https://Twitter.com/TheLancetOncolhttps://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv
Released:
Jan 2, 2024
Format:
Podcast episode

Titles in the series (100)

Editors of The Lancet Oncology and the journal’s authors explore their research and its impact on people’s health, health care, and health policy in this regular podcast.